![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: GRIK4 |
Gene summary for GRIK4 |
![]() |
Gene information | Species | Human | Gene symbol | GRIK4 | Gene ID | 2900 |
Gene name | glutamate ionotropic receptor kainate type subunit 4 | |
Gene Alias | EAA1 | |
Cytomap | 11q23.3 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | B2RAP6 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
2900 | GRIK4 | HTA11_2487_2000001011 | Human | Colorectum | SER | 2.39e-03 | 1.67e-01 | -0.1808 |
2900 | GRIK4 | HTA11_1938_2000001011 | Human | Colorectum | AD | 8.97e-05 | 2.30e-01 | -0.0811 |
2900 | GRIK4 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.82e-02 | 8.60e-02 | -0.1954 |
2900 | GRIK4 | HTA11_2992_2000001011 | Human | Colorectum | SER | 3.33e-06 | 3.88e-01 | -0.1706 |
2900 | GRIK4 | HTA11_866_3004761011 | Human | Colorectum | AD | 8.42e-03 | 1.29e-01 | 0.096 |
2900 | GRIK4 | HTA11_10623_2000001011 | Human | Colorectum | AD | 4.01e-04 | 2.50e-01 | -0.0177 |
2900 | GRIK4 | HTA11_10711_2000001011 | Human | Colorectum | AD | 1.03e-03 | 1.80e-01 | 0.0338 |
2900 | GRIK4 | HTA11_6818_2000001011 | Human | Colorectum | AD | 2.34e-02 | 2.25e-01 | 0.0112 |
2900 | GRIK4 | HTA11_11156_2000001011 | Human | Colorectum | AD | 1.02e-03 | 3.39e-01 | 0.0397 |
2900 | GRIK4 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 7.05e-05 | 2.65e-01 | 0.3859 |
2900 | GRIK4 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 3.40e-24 | 5.99e-01 | 0.3005 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
GRIK4 | SNV | Missense_Mutation | c.866N>T | p.Trp289Leu | p.W289L | Q16099 | protein_coding | deleterious(0.01) | probably_damaging(0.931) | TCGA-44-8120-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
GRIK4 | SNV | Missense_Mutation | c.655G>C | p.Ala219Pro | p.A219P | Q16099 | protein_coding | deleterious(0.01) | probably_damaging(0.912) | TCGA-44-A4SU-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
GRIK4 | SNV | Missense_Mutation | c.35N>T | p.Pro12Leu | p.P12L | Q16099 | protein_coding | tolerated(0.9) | benign(0) | TCGA-50-5049-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
GRIK4 | SNV | Missense_Mutation | c.1900N>A | p.Ser634Thr | p.S634T | Q16099 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-50-5930-01 | Lung | lung adenocarcinoma | Male | <65 | III/IV | Chemotherapy | taxotere | PD | |
GRIK4 | SNV | Missense_Mutation | c.586N>A | p.Asp196Asn | p.D196N | Q16099 | protein_coding | deleterious(0.02) | benign(0.292) | TCGA-50-5946-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | PD | |
GRIK4 | SNV | Missense_Mutation | c.1192N>A | p.Leu398Ile | p.L398I | Q16099 | protein_coding | tolerated(0.09) | probably_damaging(0.951) | TCGA-55-1595-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
GRIK4 | SNV | Missense_Mutation | c.2184N>T | p.Glu728Asp | p.E728D | Q16099 | protein_coding | tolerated(0.08) | probably_damaging(0.995) | TCGA-55-6712-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | carboplatin | PD | |
GRIK4 | SNV | Missense_Mutation | novel | c.1859N>T | p.Cys620Phe | p.C620F | Q16099 | protein_coding | deleterious(0.01) | probably_damaging(0.995) | TCGA-55-7907-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
GRIK4 | SNV | Missense_Mutation | novel | c.2453N>A | p.Val818Glu | p.V818E | Q16099 | protein_coding | deleterious(0) | possibly_damaging(0.649) | TCGA-55-7907-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
GRIK4 | SNV | Missense_Mutation | c.863N>A | p.Ser288Tyr | p.S288Y | Q16099 | protein_coding | deleterious(0) | probably_damaging(0.975) | TCGA-55-A490-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | carboplatin | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
2900 | GRIK4 | DRUGGABLE GENOME, ION CHANNEL | haloperidol | HALOPERIDOL | 27023437 | |
2900 | GRIK4 | DRUGGABLE GENOME, ION CHANNEL | antagonist | CHEMBL14935 | TEZAMPANEL | |
2900 | GRIK4 | DRUGGABLE GENOME, ION CHANNEL | antagonist | CHEMBL220492 | TOPIRAMATE | |
2900 | GRIK4 | DRUGGABLE GENOME, ION CHANNEL | TEZAMPANEL | TEZAMPANEL | ||
2900 | GRIK4 | DRUGGABLE GENOME, ION CHANNEL | antagonist | CHEMBL3545042 | SELURAMPANEL | |
2900 | GRIK4 | DRUGGABLE GENOME, ION CHANNEL | antidepressants | 19924111,17671280,23394390 | ||
2900 | GRIK4 | DRUGGABLE GENOME, ION CHANNEL | agonist | 178101000 | ||
2900 | GRIK4 | DRUGGABLE GENOME, ION CHANNEL | agonist | 178100908 | ||
2900 | GRIK4 | DRUGGABLE GENOME, ION CHANNEL | agonist | 178101004 | DYSIHERBAINE | |
2900 | GRIK4 | DRUGGABLE GENOME, ION CHANNEL | agonist | 178101048 |
Page: 1 2 |